XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Net Income (Loss) Per Share

 

 

For the Year Ended December 31,

 

 

 

2023

 

 

2022

 

Net Loss

 

$(3,402,592)

 

$(2,880,060)

Net loss attributable to common shareholders

 

$(3,402,592)

 

$(2,880,060)

Weighted average number of shares of common stock outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

19,834,476

 

 

 

19,743,544

 

Diluted

 

 

19,834,476

 

 

 

19,743,544

 

Net loss attributable to common shareholders per share:

 

 

 

 

 

 

 

 

Basic

 

$(0.17)

 

$(0.15)

Diluted

 

$(0.17)

 

$(0.15)

 

 

For the Years Ended December 31,

 

 

 

2023

 

 

2022

 

Numerator:

 

 

 

 

 

 

Net Loss

 

$(3,402,592)

 

$(2,880,060)

Denominator:

 

 

 

 

 

 

 

 

Basic weighted-average shares

 

 

19,834,476

 

 

 

19,743,544

 

Effect of dilutive securities

 

 

 

 

 

 

 

 

Warrants

 

 

-

 

 

 

-

 

Convertible Debt

 

 

-

 

 

 

-

 

Options

 

 

-

 

 

 

-

 

Preferred Stock

 

 

-

 

 

 

-

 

Diluted Weighted Average Shares

 

 

19,834,476

 

 

 

19,743,544

 

 

 

 

 

 

 

 

 

 

Net Loss Per Common Share:

 

 

 

 

 

 

 

 

 

Basic

 

$(0.17)

 

$(0.15)

Diluted

 

$(0.17)

 

$(0.15)
Disaggregation of Revenue

For The Years Ended

December 31,

 

 

               Change

 

 

 

            2023

 

 

                    2022

 

 

$

 

SteraMist Product

 

$5,695,000

 

 

$6,864,000

 

 

$(1,169,000)

Service and Training

 

 

1,660,000

 

 

 

1,474,000

 

 

 

186,000

 

Total

 

$7,355,000

 

 

$8,338,000

 

 

$(983,000)

 

 

  For The Years Ended

December 31,

 

 

Change

 

 

 

           2023

 

 

2022

 

 

$

 

United States

 

$6,125,000

 

 

$6,261,000

 

 

$(136,000)

International

 

 

1,230,000

 

 

 

2,077,000

 

 

 

(847,000)

Total

 

$7,355,000

 

 

$8,338,000

 

 

$(983,000)